Patienter med normale IGF- I koncentrationer ved behandlingens start bør have væksthormon op til et IGF- I niveau, i den øvre del af normalområdet, der ikke overstiger 2 SDS.
Patients with normal IGF-I concentrations at the start of the treatment should be administered growth hormone up to an IGF-I level into the upper range of normal, not exceeding the 2 SDS.